Chemical_Or_Drug_Has_Mechanism_Of_Action
Chemical_Or_Drug_Has_Physiologic_Effect
Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue
Cytotoxic T-Lymphocyte
T-Cell Activation
Von Hippel-Lindau Peptide Vaccine
(H115D)VHL35 Peptide
(H115D)VHL35
(H115D)VHL35 Peptide
(H115D)VHL35 Peptide
726584
A peptide vaccine derived from the von Hippel-Lindau (VHL) tumor suppressor protein, a general transcription factor. In (H115D)VHL35 peptide, histidine is substituted for an aspartic acid in position 115. It might be used to elicit or boost cellular immunity to cancers that expressing the von Hippel-Lindau mutation. (NCI04)
Amino Acid, Peptide, or Protein
C1515533
C28776
Pharmacologic Substance
_H115D_VHL35
Immunopotentiation
Antigen Sensitization